Minzhou Zhang Selected Research

tanshinone II A sodium sulfonate

10/2021	Prevention of endotoxin-induced cardiomyopathy using sodium tanshinone IIA sulfonate: Involvement of augmented autophagy and NLRP3 inflammasome suppression.
1/2021	Sodium Tanshinone IIA sulfonate for acute myocardial infarction: a systematic review and Meta-analysis.
1/2021	Efficacy of Sodium Tanshinone IIA Sulfonate in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Controlled, Randomized Trial.
1/2019	Sodium tanshinone IIA sulfonate prevents the adverse left ventricular remodelling: Focus on polymorphonuclear neutrophil-derived granule components.
1/2019	Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction.
12/2015	Rationale and Design of Sodium Tanshinone IIA Sulfonate in Left Ventricular Remodeling Secondary to Acute Myocardial Infarction (STAMP-REMODELING) Trial: A Randomized Controlled Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Minzhou Zhang Research Topics

Disease

16	Myocardial Infarction 01/2021 - 01/2012
10	Heart Failure 01/2021 - 01/2014
7	Fibrosis (Cirrhosis) 01/2022 - 01/2014
7	Infarction (Infarctions) 01/2022 - 01/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2016
5	Myocardial Ischemia (Ischemic Heart Diseases) 12/2019 - 01/2013
4	ST Elevation Myocardial Infarction 01/2022 - 12/2015
4	Sepsis (Septicemia) 10/2021 - 02/2015
4	Acute Coronary Syndrome 01/2021 - 01/2016
4	Cardiac Arrhythmias (Arrythmia) 07/2020 - 01/2013
4	Ventricular Remodeling 01/2020 - 12/2015
3	Hypertrophy 01/2022 - 04/2014
3	Coronary Disease (Coronary Heart Disease) 04/2019 - 01/2015
2	Reperfusion Injury 07/2020 - 01/2013
2	Cardiomegaly (Heart Hypertrophy) 05/2020 - 01/2014
2	Hypertension (High Blood Pressure) 05/2020 - 01/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 04/2019 - 01/2013
2	Heart Diseases (Heart Disease) 01/2019 - 01/2019
2	Atrial Fibrillation 01/2019 - 10/2016
2	Inflammation (Inflammations) 01/2018 - 01/2018
2	Angina Pectoris 12/2017 - 11/2016
2	Septic Shock (Toxic Shock Syndrome) 02/2016 - 02/2015
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 10/2021
1	Endotoxemia 10/2021
1	Thrombosis (Thrombus) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2020
1	Obesity 01/2020
1	Pneumonia (Pneumonitis) 01/2019
1	Tachycardia (Tachyarrhythmias) 01/2019
1	Critical Illness (Critically Ill) 01/2019
1	Heat Stroke (Heatstroke) 06/2017
1	Lung Injury 06/2017
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2015
1	Stable Angina 01/2015
1	Compartment Syndromes 01/2014
1	Sprains and Strains (Sprain) 01/2014

Drug/Important Bio-Agent (IBA)

7	Capsules (Microcapsules)IBA 05/2020 - 01/2013
6	tanshinone II A sodium sulfonateIBA 10/2021 - 12/2015
6	tongguanIBA 07/2020 - 01/2013
4	CytokinesIBA 01/2022 - 04/2019
4	TabletsIBA 04/2019 - 01/2014
3	tanshinoneIBA 01/2021 - 04/2014
3	XuebijingIBA 01/2019 - 02/2015
2	InflammasomesIBA 01/2022 - 10/2021
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2013
2	xinmailongIBA 01/2021 - 01/2017
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 05/2020 - 12/2017
2	Indicators and Reagents (Reagents)IBA 12/2019 - 04/2016
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2014
2	Therapeutic UsesIBA 02/2015 - 01/2015
1	EndotoxinsIBA 10/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	SodiumIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	songling xuemaikangIBA 05/2020
1	Metoprolol (Toprol-XL)FDA LinkGeneric 05/2020
1	Pharmaceutical PreparationsIBA 05/2020
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2019
1	xinkeshuIBA 04/2019
1	CollagenIBA 01/2019
1	omega-Chloroacetophenone (Mace)IBA 01/2019
1	Connexin 43 (Connexin43)IBA 01/2019
1	danqi tongmaiIBA 01/2019
1	polyethylene glycol 1000IBA 01/2018
1	methoxy poly(ethylene glycol)-poly(lactide)IBA 01/2018
1	Succinic Acid (Succinate)IBA 01/2018
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2018
1	poly(lactide) (polylactic acid)IBA 01/2018
1	Sirtuin 1IBA 01/2018
1	tocophersolanIBA 01/2018
1	shexiang tongxinIBA 12/2017
1	Interleukin-10 (Interleukin 10)IBA 06/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2017
1	HDL CholesterolIBA 01/2017
1	pro-brain natriuretic peptide (1-76)IBA 10/2016
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2016
1	danlou tabletIBA 01/2016
1	salvianolic acid BIBA 01/2016
1	Sodium Chloride FDA LinkGeneric 02/2015
1	danhongIBA 01/2015
1	Nonprescription Drugs (Patent Medicines)IBA 01/2015
1	Verapamil (Calan)FDA LinkGeneric 01/2013
1	VER I (WER I)IBA 01/2013

Therapy/Procedure

8	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 01/2014
5	Percutaneous Coronary Intervention 01/2022 - 12/2015
5	Therapeutics 07/2020 - 01/2014
2	Ligation 01/2019 - 01/2018
2	Critical Care (Surgical Intensive Care) 02/2016 - 02/2015
1	Stents 01/2021
1	Cardiac Rehabilitation 01/2021
1	Qigong (Qi Gong) 01/2021
1	Intraperitoneal Injections 05/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2019
1	Length of Stay 01/2012